Health Care Access and Affordability Among US Adults Aged 18 to 64 Years With Self-reported Post-COVID-19 Condition.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
03 04 2023
03 04 2023
Historique:
medline:
12
4
2023
entrez:
10
4
2023
pubmed:
11
4
2023
Statut:
epublish
Résumé
Many US adults report having post-COVID-19 condition (PCC), but little is known about their access to health care. To estimate the association of PCC with access and affordability challenges among US adults aged 18 to 64 years. This survey study used data from the Health Reform Monitoring Survey, a probability-based internet survey conducted June 17 to July 5, 2022. Participants included a nationally representative sample of 9484 US adults ages 18 to 64 years drawn from the Ipsos KnowledgePanel. Self-reported PCC was defined as experiencing symptoms more than 4 weeks after first having COVID-19 that were not explained by another condition or factor. Access and affordability outcomes included having a usual place of care; forgoing care in the past 12 months because of costs, difficulty finding clinicians, or difficulty using health insurance; having problems paying family medical bills in the past 12 months; and having past-due medical debt. Of 19 162 panel members recruited for the survey, 9599 individuals completed the survey (completion rate, 50.1%) and 9484 respondents were included in the final analytic sample (4720 females [50.6%, weighted]; mean [SD] age, 41.0 [13.5] years). A total of 3382 respondents (36.4%; 95% CI, 34.7%-38.2%) reported ever being diagnosed with COVID-19, among whom, 833 respondents (22.5%; 95% CI, 20.9%-24.2%) reported currently having PCC. After adjustment for differences in demographic, health, and geographic characteristics, adults with PCC were more likely than 2549 adults with a COVID-19 diagnosis but no report of PCC and 6102 adults never diagnosed with COVID-19 to report unmet health care needs in the past 12 months because of the following challenges: costs (27.0%; 95% CI, 23.2%-30.7% vs 18.3%; 95% CI, 15.9%-20.7% and 17.5%; 95% CI, 15.4%-19.6%) and difficulties finding clinicians accepting new patients (16.4%; 95% CI, 14.3%-18.4% vs 10.1%; 95% CI, 8.8%-11.5% and 10.7%; 95% CI, 9.6%-11.8%), getting a timely appointment (22.0%; 95% CI, 19.3%-24.8% vs 14.4%; 95% CI, 13.2%-15.7% and 13.9%; 95% CI, 12.9%-14.8%), and getting health plan care authorization (16.6%; 95% CI, 14.6%-18.6% vs 10.8%; 95% CI, 9.6%-12.1% and 10.3%; 95% CI, 9.4%-11.2%) (P < .001 for all comparisons). This study found that adults aged 18 to 64 years with PCC were more likely than other adults to have difficulty getting and paying for health care. These findings suggest that policies aimed at improving access and affordability may focus on accelerating development of treatments and clinical guidelines, training clinicians, and addressing insurance-related administrative and cost barriers.
Identifiants
pubmed: 37036705
pii: 2803645
doi: 10.1001/jamanetworkopen.2023.7455
pmc: PMC10087049
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e237455Références
EClinicalMedicine. 2021 Aug;38:101019
pubmed: 34308300
BMJ. 2021 May 19;373:n1098
pubmed: 34011492
JAMA Netw Open. 2022 Nov 1;5(11):e2240332
pubmed: 36326761
BMJ. 2021 Mar 31;372:n693
pubmed: 33789877
Lancet. 2022 Aug 6;400(10350):452-461
pubmed: 35934007
N Engl J Med. 2021 Aug 12;385(7):577-579
pubmed: 34192429
MMWR Morb Mortal Wkly Rep. 2022 Aug 05;71(31):993-999
pubmed: 35925799
Health Aff (Millwood). 2014 Jan;33(1):161-7
pubmed: 24352654
JAMA Netw Open. 2022 Oct 3;5(10):e2235089
pubmed: 36201207
Soc Sci Med. 2021 Jan;268:113426
pubmed: 33199035
Milbank Q. 2021 Jun;99(2):519-541
pubmed: 33783907
Nat Commun. 2021 Nov 12;12(1):6571
pubmed: 34772922
JAMA. 2022 Aug 16;328(7):676-678
pubmed: 35796131
N Engl J Med. 2020 Oct 22;383(17):1603-1606
pubmed: 32813967
Lancet Respir Med. 2021 Feb;9(2):129
pubmed: 33453162
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
Nature. 2021 Jun;594(7862):259-264
pubmed: 33887749
J Med Virol. 2022 Jan;94(1):253-262
pubmed: 34463956
BMJ. 2022 May 18;377:e069676
pubmed: 35584816
BMC Health Serv Res. 2009 Jan 20;9:13
pubmed: 19154587
Health Serv Res. 2021 Oct;56(5):755-765
pubmed: 34498259
BMC Health Serv Res. 2022 Aug 8;22(1):1010
pubmed: 35941617
Nat Med. 2022 Jul;28(7):1461-1467
pubmed: 35614233
JAMA Netw Open. 2021 Oct 1;4(10):e2128568
pubmed: 34643720
PLoS Med. 2021 Sep 28;18(9):e1003773
pubmed: 34582441
Nat Commun. 2022 Jun 28;13(1):3528
pubmed: 35764621
Health Aff (Millwood). 2016 Jan;35(1):161-8
pubmed: 26674536
Lancet Psychiatry. 2022 Oct;9(10):815-827
pubmed: 35987197
Nat Rev Microbiol. 2023 Mar;21(3):133-146
pubmed: 36639608
Science. 2021 Jul 30;373(6554):491-493
pubmed: 34326224
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
JAMA Netw Open. 2022 Jul 1;5(7):e2224359
pubmed: 35904783
JAMA Netw Open. 2021 Feb 1;4(2):e210830
pubmed: 33606031
BMJ. 2021 Dec 29;375:e065834
pubmed: 34965929